Cabaletta Bio, Inc.

CABA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$45-$45-$36-$33
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$6$5$0
Change in WC$0$4-$3$3
Other Non-Cash$4$4$3$6
Operating Cash Flow-$35-$30-$31-$23
Investing Activities
PP&E Inv.-$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$50-$49$0$0
Inv. Sales/Matur.$0$0$0$13
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$50-$49-$1$12
Financing Activities
Debt Repay.-$1-$3-$1-$1
Stock Issued-$0$96$0$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$1$93-$1$4
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$85$14-$32-$7
Supplemental Information
Beg. Cash$146$132$164$171
End Cash$60$146$132$164
Free Cash Flow-$35-$31-$32-$23
Cabaletta Bio, Inc. (CABA) Financial Statements & Key Stats | AlphaPilot